1. Home
  2. YMAT vs AIMD Comparison

YMAT vs AIMD Comparison

Compare YMAT & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAT
  • AIMD
  • Stock Information
  • Founded
  • YMAT 1970
  • AIMD 1984
  • Country
  • YMAT Taiwan
  • AIMD United States
  • Employees
  • YMAT N/A
  • AIMD N/A
  • Industry
  • YMAT Recreational Games/Products/Toys
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • YMAT Consumer Discretionary
  • AIMD Health Care
  • Exchange
  • YMAT Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • YMAT 15.3M
  • AIMD 16.9M
  • IPO Year
  • YMAT 2025
  • AIMD N/A
  • Fundamental
  • Price
  • YMAT $0.81
  • AIMD $2.27
  • Analyst Decision
  • YMAT
  • AIMD
  • Analyst Count
  • YMAT 0
  • AIMD 0
  • Target Price
  • YMAT N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • YMAT 1.9M
  • AIMD 34.6K
  • Earning Date
  • YMAT 04-29-2026
  • AIMD 11-13-2025
  • Dividend Yield
  • YMAT N/A
  • AIMD N/A
  • EPS Growth
  • YMAT N/A
  • AIMD N/A
  • EPS
  • YMAT 0.07
  • AIMD N/A
  • Revenue
  • YMAT $17,563,985.00
  • AIMD $110,870.00
  • Revenue This Year
  • YMAT N/A
  • AIMD N/A
  • Revenue Next Year
  • YMAT N/A
  • AIMD N/A
  • P/E Ratio
  • YMAT $11.86
  • AIMD N/A
  • Revenue Growth
  • YMAT N/A
  • AIMD 70.25
  • 52 Week Low
  • YMAT $0.79
  • AIMD $2.00
  • 52 Week High
  • YMAT $6.45
  • AIMD $5.00
  • Technical
  • Relative Strength Index (RSI)
  • YMAT N/A
  • AIMD 28.33
  • Support Level
  • YMAT N/A
  • AIMD $2.59
  • Resistance Level
  • YMAT N/A
  • AIMD $3.16
  • Average True Range (ATR)
  • YMAT 0.00
  • AIMD 0.24
  • MACD
  • YMAT 0.00
  • AIMD -0.11
  • Stochastic Oscillator
  • YMAT 0.00
  • AIMD 0.00

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: